Evidence map›Paper›PMID 24074852›Full record

Trial reportJournal of substance abuse treatment2014

Psychometric properties of the adjective rating scale for withdrawal across treatment groups, gender, and over time.

Celestina Barbosa-Leiker, Sterling McPherson, Mary Rose Mamey, G Leonard Burns, John Roll

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of substance abuse treatment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Celestina Barbosa-LeikerWashington State University, College of Nursing, PO Box 1495, Spokane, WA, 99210-1495, USA; Department of Psychology, Washington State University, PO Box 4820, Pullman, WA, 99164-4820, USA; Programs of Excellence in Addictions Research, Washington State University, Pullman, WA 99164-4820, USA; Translational Addictions Research Center, Washington State University, Pullman, WA 99164-4820, USA. Electronic address: celestina@wsu.edu.
Sterling McPherson
Mary Rose Mamey
G Leonard Burns
John Roll
Washington State University · USWashington State University Spokane · US

Funding

CLINICAL TRIALS NETWORK: PACIFIC NORTHWEST NODEU10DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI DONOVAN, DENNIS MICHAEL, ROLL, JOHN M. · 2001 to 2015
$25.5M
STATISTICAL SUPPORT/DATA MANAGEMENT COREP30DA016383 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2005 to 2015
$8.6M
NIDA NIH HHS 5 U10 DA013714-10NIDA NIH HHS P30 DA016383NIDA NIH HHS P30DA016383NIDA NIH HHS U10 DA013714
6 · The paper itself

Abstract

The adjective rating scale for withdrawal (ARSW) is commonly used to assess opiate withdrawal in clinical practice and research. The aims of this study were to examine the factor structure of the ARSW, test measurement invariance across gender and treatment groups, and assess longitudinal measurement invariance across the clinical trial. Secondary data analysis of the National Drug Abuse Treatment Clinical Trials Network 000-3, a randomized clinical trial comparing two tapering strategies, was performed. The ARSW was analyzed at baseline, end of taper and 1-month follow-up (N=515 opioid-dependent individuals). A 1-factor model of the ARSW fit the data and demonstrated acceptable reliability. Measurement invariance was supported across gender and taper groups. Longitudinal measurement invariance was not found across the course of the trial, with baseline assessment contributing to the lack of invariance. If change over time is of interest, change from post-treatment through follow-up may offer the most valid comparison.

Indexed as

Psychiatric Status Rating ScalesAdultBuprenorphineBuprenorphine, Naloxone Drug CombinationFemaleFollow-Up StudiesHumansLongitudinal StudiesMaleMiddle AgedNaloxoneOpioid-Related DisordersPsychometricsReproducibility of ResultsSex FactorsSubstance Withdrawal SyndromeBuprenorphineBuprenorphine, Naloxone Drug CombinationNaloxoneMeasurement invarianceOpiate dependenceOpiate withdrawalPsychometrics

Identifiers

PMID24074852
PMCPMC3870009
OpenAlexW2075892750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.